Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Crescent Capital BDC FY 2024 Adj. EPS $2.40 Misses $2.42 Estimate, Sales $197.363M Miss $198.220M Estimate

Author: Benzinga Newsdesk | February 19, 2025 04:33pm
Crescent Capital BDC (NASDAQ:CCAP) reported quarterly earnings of $2.40 per share which missed the analyst consensus estimate of $2.42 by 0.83 percent. The company reported quarterly sales of $197.363 million which missed the analyst consensus estimate of $198.220 million by 0.43 percent.

Posted In: CCAP

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist